When artificial intelligence supports the work of doctors, the French are more in favor of its development.
- Artificial intelligence is “the set of theories and techniques implemented in order to produce machines capable of simulating human intelligence”.
- It therefore encompasses a set of concepts and technologies, more than an autonomous constituted discipline.
More than 1 in 2 French people are in favor of using artificial intelligence against cancer, according to a new Viavoice survey for Eurekam. “Questioned on the subject, the French are confident about the use of artificial intelligence as support for expertise and the implementation of care”, write the authors of the survey.
Relevant added value
The analysis of data in the context of disease prevention (71%), the support of professionals for better precision of drug dosages (62%) or even surgical procedures (60%) are all situations for which the Artificial intelligence appears to be a relevant added value in the eyes of the French. 64% of our fellow citizens also believe that artificial intelligence could help prevent medication errors.
“On the other hand, they are more nuanced about his intervention in the context of consultations and diagnoses, stages during which the human relationship takes on a more important character”, note the pollsters. In the same vein, they are only 56% to find reassuring the fact that artificial intelligence partly controls the identity and the dosage of the products administered to patients in the context of anticancer treatments.
A very unconstructed opinion
Despite this openness in principle to the subject, the results also show a very little constructed opinion: a third of French people thus declare that they do not know whether artificial intelligence today plays an important role in the prevention of medication errors and 44% think this is not the case.
.
